Denosumab Discontinuation in Patients Treated for Low Bone Density and Osteoporosis. Zeytinoglu M, Naaman SC, Dickens LT. Endocrinol Metab Clin North Am 2021;50:205-222.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zeytinoglu M, Naaman SC, Dickens LT. Denosumab Discontinuation in Patients Treated for Low Bone Density and Osteoporosis. Endocrinol Metab Clin North Am 2021;50:205-222.
PMID: 34023039